SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001640334-21-000874
Filing Date
2021-04-13
Accepted
2021-04-13 16:07:00
Documents
44
Period of Report
2021-02-28

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q artl_10q.htm 10-Q 639566
2 EX-31.1 artl_ex311.htm EX-31.1 10068
3 EX-32.1 artl_ex321.htm EX-32.1 3900
  Complete submission text file 0001640334-21-000874.txt   3095736

Data Files

Seq Description Document Type Size
4 XBRL INSTANCE DOCUMENT artl-20210228.xml EX-101.INS 338464
5 XBRL TAXONOMY EXTENSION SCHEMA artl-20210228.xsd EX-101.SCH 49197
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE artl-20210228_cal.xml EX-101.CAL 25209
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE artl-20210228_def.xml EX-101.DEF 107080
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE artl-20210228_lab.xml EX-101.LAB 661458
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE artl-20210228_pre.xml EX-101.PRE 213948
Mailing Address 888 PROSPECT STREET, SUITE 210 LA JOLLA CA 92037
Business Address 888 PROSPECT STREET, SUITE 210 LA JOLLA CA 92037 760-943-1689
ARTELO BIOSCIENCES, INC. (Filer) CIK: 0001621221 (see all company filings)

IRS No.: 331220924 | State of Incorp.: NV | Fiscal Year End: 0831
Type: 10-Q | Act: 34 | File No.: 001-38951 | Film No.: 21823156
SIC: 2834 Pharmaceutical Preparations